PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
18.28%
Revenue growth similar to 6617.T's 19.34%. Walter Schloss would see if both companies share industry tailwinds.
14.06%
Gross profit growth above 1.5x 6617.T's 7.80%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
2.39%
Positive EBIT growth while 6617.T is negative. John Neff might see a substantial edge in operational management.
41.30%
Positive operating income growth while 6617.T is negative. John Neff might view this as a competitive edge in operations.
-38.44%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-38.37%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-38.09%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.03%
Share reduction while 6617.T is at 0.01%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.03%
Reduced diluted shares while 6617.T is at 0.01%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.73%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-21.98%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-23.01%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-78.75%
Negative 10Y net income/share CAGR while 6617.T is at 159.83%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-70.48%
Negative 5Y net income/share CAGR while 6617.T is 29.12%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-81.25%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
268.61%
10Y equity/share CAGR above 1.5x 6617.T's 10.56%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
54.47%
5Y equity/share CAGR above 1.5x 6617.T's 8.74%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
21.53%
3Y equity/share CAGR above 1.5x 6617.T's 7.65%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
15.66%
AR growth well above 6617.T's 14.97%. Michael Burry fears inflated revenue or higher default risk in the near future.
-22.64%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
3.44%
Asset growth above 1.5x 6617.T's 1.71%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
3.60%
BV/share growth above 1.5x 6617.T's 1.11%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-33.71%
We’re deleveraging while 6617.T stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
18.29%
R&D dropping or stable vs. 6617.T's 320.14%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
8.68%
We expand SG&A while 6617.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.